Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Communications (27)
Nature Immunology (10)
Cellular & Molecular Immunology (9)
Nature (7)
Cell Research (6)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (65)
Reviews (11)
Amendments and Corrections (8)
Correspondence (3)
Research Highlights (2)
Comments & Opinion (1)
Editorial (1)
News & Views (1)

Subject Check one or more subjects to show results from those subjects only.

Anatomy
Biochemistry
Biological techniques
Biomarkers
Biotechnology
Cancer
Cell biology
Chemistry
Diseases
Drug discovery
Genetics
Health care
Immunology
Materials science
Microbiology
Molecular biology
Nanoscience and technology
Oncology
Pathogenesis
Scientific community

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 51–92 of 92 results

Advanced filters: Author: Yang-xin Fu Clear advanced filters

Author Correction: The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy

Gui-Zhen Wang
Li Zhang
Guang-Biao Zhou
Amendments and CorrectionsOpen Access22 Jun 2022
Nature Communications

Volume: 13, P: 1-2
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease

Yonglian Sun
Helen M. Chen
Yang-Xin Fu
Research11 Nov 2002
Nature Medicine

Volume: 8, P: 1405-1413
Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity

The presence of lymph node-like vasculature in tumours correlates with positive prognosis, but the mechanisms by which it forms and affects tumour growth are unclear. Here the authors show that it is induced by CD8 and NK cells, and supports naive T cells’ differentiation into antitumour effectors.

J. David Peske
Elizabeth D. Thompson
Victor H. Engelhard
Research13 May 2015
Nature Communications

Volume: 6, P: 1-15
Priming of naive T cells inside tumors leads to eradication of established tumors

Ping Yu
Youjin Lee
Yang-Xin Fu
Research04 Jan 2004
Nature Immunology

Volume: 5, P: 141-149
Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production

Hyung-Sik Kang
Robert K. Chin
Yang-Xin Fu
Research13 May 2002
Nature Immunology

Volume: 3, P: 576-582
Lymphotoxin pathway directs thymic Aire expression

Robert K Chin
James C Lo
Yang-Xin Fu
Research28 Sept 2003
Nature Immunology

Volume: 4, P: 1121-1127
LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration

Lymphoid progenitors migrate from the bone marrow into the thymus to give rise to T and NK cell lineages. Here the authors characterize a lymphotoxin receptor beta-dependent population of thymic endothelial cells that guide lymphoid progenitor homing in the thymus.

Yaoyao Shi
Weiwei Wu
Mingzhao Zhu
ResearchOpen Access05 Aug 2016
Nature Communications

Volume: 7, P: 1-12
GITR subverts Foxp3⁺ Tregs to boost Th9 immunity through regulation of histone acetylation

Glucocorticoid-induced TNFR-related protein (GITR), a costimulatory protein expressed by T cells, has immunostimulatory effect but the underlying mechanism is not clear. Here the authors show that GITR ligation inhibits the induction of Foxp3 expression and diverts CD4 T cells towards Th9 differentiation instead of iTreg.

Xiang Xiao
Xiaomin Shi
Xian Chang Li
ResearchOpen Access14 Sept 2015
Nature Communications

Volume: 6, P: 1-13
Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

Koji Tamada
Koji Shimozaki
Lieping Chen
Research01 Mar 2000
Nature Medicine

Volume: 6, P: 283-289
Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication

Yong Liang
Kaiting Yang
Hua Peng
ResearchOpen Access20 May 2015
Scientific Reports

Volume: 5, P: 1-10
Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy

Combining immune checkpoint inhibition with radiotherapy–radiodynamic therapy, enabled by intratumorally injected nanoscale metal–organic frameworks, promotes systemic antitumour immunity and tumour rejection in mouse models of breast and colorectal cancer.

Kuangda Lu
Chunbai He
Wenbin Lin
Research26 Mar 2018
Nature Biomedical Engineering

Volume: 2, P: 600-610
B and T lymphocyte attenuator regulates CD8⁺ T cell–intrinsic homeostasis and memory cell generation

Carsten Krieg
Onur Boyman
Jonathan Kaye
Research07 Jan 2007
Nature Immunology

Volume: 8, P: 162-171
OX40 signaling favors the induction of T_H9 cells and airway inflammation

T_H9 cells secrete copious amounts of IL-9, but how their generation is controlled remains poorly defined. Li and colleagues demonstrate that ligation of the costimulatory receptor OX40 potently generates T_H9 cells in a manner dependent on noncanonical NF-κB signaling.

Xiang Xiao
Savithri Balasubramanian
Xian Chang Li
Research29 Jul 2012
Nature Immunology

Volume: 13, P: 981-990
Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8⁺ T cells

Xue Wang
Longchao Liu
Yang-Xin Fu
ResearchOpen Access12 Jul 2023
Signal Transduction and Targeted Therapy

Volume: 8, P: 1-3
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2

Shiyu Sun
Yueqi Cai
Hua Peng
ResearchOpen Access15 Jul 2021
Cell Research

Volume: 31, P: 1011-1023
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

The receptor LILRB4 on monocytic leukaemia cells suppresses T cell activity and support the infiltration of tumour cells into tissues.

Mi Deng
Xun Gui
Cheng Cheng Zhang
Research17 Oct 2018
Nature

Volume: 562, P: 605-609
Innate and adaptive immune cells in the tumor microenvironment

Tumors can evade immune system–mediated destruction despite expressing antigenic neoepitopes. Gajewski, Schreiber and Fu discuss how the tumor microenvironment harnesses innate and adaptive immune cell regulatory processes to promote tumor survival.

Thomas F Gajewski
Hans Schreiber
Yang-Xin Fu
Reviews18 Sept 2013
Nature Immunology

Volume: 14, P: 1014-1022
Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity

Jingya Guo
Yong Liang
Hua Peng
Research10 Aug 2021
Cell Research

Volume: 31, P: 1190-1198
T cell-derived lymphotoxin limits Th1 response during HSV-1 infection

Kaiting Yang
Yong Liang
Hua Peng
ResearchOpen Access07 Dec 2018
Scientific Reports

Volume: 8, P: 1-9
Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine

Zhida Liu
Chang Zhou
Wei Liang
ResearchOpen Access04 Apr 2017
Cell Discovery

Volume: 3, P: 1-14
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation

Yuan Zhang
Tae-Jin Kim
Yang-Xin Fu
Research05 Jun 2017
Cellular & Molecular Immunology

Volume: 15, P: 697-709
A STING-activating nanovaccine for cancer immunotherapy

STING-activating nanoparticle vaccines achieve robust activation of tumour-specific T cells for cancer immunotherapy.

Min Luo
Hua Wang
Jinming Gao
Research24 Apr 2017
Nature Nanotechnology

Volume: 12, P: 648-654
Targeting innate sensing in the tumor microenvironment to improve immunotherapy

Zhida Liu
Chuanhui Han
Yang-Xin Fu
Reviews16 Dec 2019
Cellular & Molecular Immunology

Volume: 17, P: 13-26
A mouse model for HBV immunotolerance and immunotherapy

Dan Yang
Longchao Liu
Liguo Zhang
Research30 Sept 2013
Cellular & Molecular Immunology

Volume: 11, P: 71-78
Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy

Chuanhui Han
Anli Zhang
Yang-Xin Fu
Reviews07 Dec 2020
Oncogene

Volume: 40, P: 885-898
Phagocytosis checkpoints as new targets for cancer immunotherapy

Innate immune checkpoints, including those regulating tumour detection and phagocytosis, have emerged as potential cancer immunotherapy targets. This Review discusses the role of phagocytosis checkpoints in cancer immune evasion, highlighting the preclinical and early clinical evidence supporting phagocytosis checkpoint blockade.

Mingye Feng
Wen Jiang
Irving L. Weissman
Reviews28 Aug 2019
Nature Reviews Cancer

Volume: 19, P: 568-586
Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01

Shiyu Sun
Xi Chen
Hua Peng
CorrespondenceOpen Access30 Nov 2021
Cell Discovery

Volume: 7, P: 1-3
Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2

Shiyu Sun
Yueqi Cai
Hua Peng
Amendments and Corrections20 Sept 2021
Cell Research

Volume: 31, P: 1222
Chinese scientists and US leadership in the life sciences

Steven H. Holtzman
Ron Cohen
Shuguang Zhang
Correspondence03 Oct 2019
Nature Biotechnology

Volume: 37, P: 1261-1263
LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity

Yanyan Wang
Xingrong Du
Hongbo Chi
Research25 Mar 2019
Cell Research

Volume: 29, P: 391-405
Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity

Chao Zhang
Jin Feng
Hong Tang
Research15 May 2017
Cellular & Molecular Immunology

Volume: 15, P: 973-982
A novel method for synthetic vaccine construction based on protein assembly

Zhida Liu
Hang Zhou
Mingzhao Zhu
ResearchOpen Access01 Dec 2014
Scientific Reports

Volume: 4, P: 1-8
Inactivation of TGF-β signaling in CAR-T cells

Zaopeng Yang
Yang-Xin Fu
Comments & Opinion26 Feb 2024
Cellular & Molecular Immunology

Volume: 21, P: 309-310
Cytokines that target immune killer cells against tumors

Jian Qiao
Yang-Xin Fu
Reviews10 Jun 2020
Cellular & Molecular Immunology

Volume: 17, P: 722-727
Towards developing a variant-proof SARS-CoV-2 vaccine

Hua Peng
Yang-Xin Fu
Research Highlights02 Jan 2023
Cell Research

Volume: 33, P: 5-6
Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine

Hua Peng
Yang-Xin Fu
Research Highlights08 Mar 2022
Cell Research

Volume: 32, P: 331-332
Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2

Yifan Lin
Jing Sun
Hua Peng
CorrespondenceOpen Access10 May 2022
Cell Discovery

Volume: 8, P: 1-4
Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy

Haidong Tang
Mingzhao Zhu
Yang-Xin Fu
Reviews17 Apr 2017
Cellular & Molecular Immunology

Volume: 14, P: 809-818
New immune therapy targets tumor-associated environment: from bone marrow to tumor site

Yang-Xin Fu
Editorial12 Dec 2011
Cellular & Molecular Immunology

Volume: 9, P: 1-2
Tumor-infiltrating T lymphocytes: friends or foes?

Ping Yu
Yang-Xin Fu
Reviews30 Jan 2006
Laboratory Investigation

Volume: 86, P: 231-245
Targeting and utilizing primary tumors as live vaccines: changing strategies

Xuanming Yang
Eric D Mortenson
Yang-Xin Fu
Reviews21 Nov 2011
Cellular & Molecular Immunology

Volume: 9, P: 20-26
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy

M Michelle Xu
Y Pu
Y-X Fu
Reviews18 Jul 2016
Oncogene

Volume: 36, P: 585-592

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Italy
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited